A carregar...

A comprehensively revised strategy that improves the specific activity and long-term stability of clinically relevant (89)Zr-immuno-PET agents

Zirconium-89 is currently being used in numerous clinical trials involving monoclonal antibodies and positron emission tomography. This report describes a revised strategy that reduces preparation time while increasing the specific activity of clinically relevant immuno-PET agents. Additionally, it...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Dalton Trans
Main Authors: Bhatt, Nikunj B., Pandya, Darpan N., Rideout-Danner, Stephanie, Gage, Howard D., Marini, Frank C., Wadas, Thaddeus J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6192516/
https://ncbi.nlm.nih.gov/pubmed/30178793
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/c8dt01841c
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!